FDA Focus: What Arnold & Porter's Practice Chair Is Watching

By Jeff Overley (November 27, 2018, 7:15 PM EST) -- Dan Kracov, co-chair of the U.S. Food and Drug Administration practice at Arnold & Porter, tells Law360 he's eyeing a new frontier in kickback suits against drugmakers and a trend toward "consumerization" of medical products and services once available only in doctors' offices.

Dan Kracov Kracov, who is based in Washington, D.C., has been immersed in FDA law for three decades. He's a BigLaw lifer who has been at Arnold & Porter since 2005 and previously practiced at Patton Boggs LLP — now Squire Patton Boggs LLP — starting in 1988.

A graduate of the University of Maryland and the University...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!